ClinConnect ClinConnect Logo
Search / Trial NCT06147141

Effectiveness and Mechanism of Online Peer Companion Intervention on Children With Autism Spectrum Disorders

Launched by PEKING UNIVERSITY · Nov 19, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Autism Spectrum Disorders Peer Mediated Intervention Children

ClinConnect Summary

This clinical trial is looking at a program called Online Peer Companion Intervention (OPCI) to see how it helps children with Autism Spectrum Disorders (ASD). The main goals are to find out if this online support can improve the social skills and mental health of children with mild ASD, as well as to see how it affects the social abilities and mental health of typically developing children and their parents. Researchers want to understand how this program works to benefit these children.

To participate, children with mild ASD should be between 7 and 15 years old, able to communicate well with others, and have access to a device like a phone or tablet for online sessions. Meanwhile, typically developing children eligible for the study are aged 9 to 18, outgoing, and also able to use electronic devices. Participants can expect to engage in online activities that encourage social interaction and support, which may help improve their social skills and overall well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria of ASD Children:
  • 7-15 years old and diagnosed as mild ASD;
  • Basic ability to speak independently and fluently communicate with peers;
  • Could use mobile phones, tablets, computers, or other electronic devices for this online intervention.
  • Exclusion Criteria of ASD Children:
  • Diagnosed as moderate or severe ASD;
  • Unable or unwilling to communicate with peers independently
  • No phones or other alternative electronic devices for the intervention Inclusion
  • Criteria of Ordinary Children:
  • 9-18 years old with normal development, no diagnosis of ASD, learning disabilities, ADHD, and other mental disorders;
  • Lively and outgoing, able to assume the role of topic organizer in communication with peers;
  • Could use mobile phones, tablets, computers, or other electronic devices for this online intervention.
  • Exclusion Criteria of Ordinary Children
  • Diagnosis of ASD or other neurodevelopmental and mental disorders;
  • Introverted or unwilling to play with peer ASD children
  • No phones or other alternative electronic devices for the intervention

About Peking University

Peking University is a prestigious institution located in Beijing, China, recognized for its commitment to advancing medical research and education. As a clinical trial sponsor, Peking University leverages its extensive academic resources and collaborative networks to drive innovative healthcare solutions. The university's focus on rigorous scientific methodologies and adherence to ethical standards ensures the integrity and reliability of its clinical research initiatives. By fostering interdisciplinary partnerships, Peking University aims to translate groundbreaking discoveries into tangible health benefits, contributing to the global advancement of medical science.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported